Last reviewed · How we verify

Cervical ripening, labor induction, Dinoprostone

Ankara University · Phase 1 active Small molecule Quality 3/100

Cervical ripening, labor induction, Dinoprostone is a Small molecule drug developed by Ankara University. It is currently in Phase 1 development.

At a glance

Generic nameCervical ripening, labor induction, Dinoprostone
SponsorAnkara University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Cervical ripening, labor induction, Dinoprostone

What is Cervical ripening, labor induction, Dinoprostone?

Cervical ripening, labor induction, Dinoprostone is a Small molecule drug developed by Ankara University.

Who makes Cervical ripening, labor induction, Dinoprostone?

Cervical ripening, labor induction, Dinoprostone is developed by Ankara University (see full Ankara University pipeline at /company/ankara-university).

What development phase is Cervical ripening, labor induction, Dinoprostone in?

Cervical ripening, labor induction, Dinoprostone is in Phase 1.

Related